This company provides a 2-in-1 reusable monitor system for integrated pregnancy and ovulation testing. Its proprietary technology accurately quantifies low levels of LH for precise ovulation tracking and detects hCG for early pregnancy confirmation. The system offers quick results, app data offloading, and utilizes bio-based, refillable test strips.
Funding
$580K raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Founders
Product
Problem
Traditional single-use pregnancy tests contribute to significant plastic waste and can be costly for frequent users. Current testing methods lack sustainability and can be environmentally burdensome due to disposable components.
Solution
Pharmista Technologies is developing a reusable, highly sensitive pregnancy test that aims to reduce waste and provide a more sustainable solution for women's health monitoring. The product consists of a small, handheld monitor and replaceable paper strips that transfer urine to the test zone, ensuring hygiene and affordability. Utilizing synthetically produced affinity reagents (SARs), the technology allows for multiple measurements with high affinity and selectivity. This platform technology has the potential to be expanded to develop reusable diagnostics for other conditions in the future.
Target Audience
The primary target audience includes women seeking a sustainable, reliable, and affordable method for monitoring their reproductive health, as well as environmentally conscious consumers.
Features
- Reusable handheld monitor for pregnancy testing
- Replaceable paper strips for hygienic sample transfer
- Synthetic affinity reagents (SARs) for high target affinity and selectivity
- Robust SARs that withstand high temperatures and pH changes
- High reproducibility with batch sizes exceeding 100,000 measurements
- Animal-free production of SARs
- Versatile SARs adaptable to various diagnostic targets